Baudax Bio Inc Asset Turnover Ratio (BXRX), as of third quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Baudax Bio Inc   (NASDAQ: BXRX)
 

Baudax Bio Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Sep 30 2023, Baudax Bio Inc has not recorded any assets.
Visit Baudax Bio Inc Balance sheet

Within sector Baudax Bio Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Third Quarter 2023 compared to previous quarter at no. .

Asset Turnover Ratio Definition



BXRX Asset Turnover Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Asset Change 1.12 % -55 % -85.53 % -81.17 % -71.53 %
Y / Y Revenue Change - - - -22.75 % -15.3 %
Asset Turnover Ratio (TTM) - - - 0.04 0.03
BXRX's Total Ranking # # # # #
Seq. Asset Change -3.65 % 160.11 % -29.58 % -42.71 % -57.12 %
Seq. Revenue Change - - - 29.83 % -20.67 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Assets at quarter ending Sep 30 2023
Gritstone Bio Inc   0.05 $ 10.225  Millions$ 215.137  Millions
Verrica Pharmaceuticals Inc   0.05 $ 3.204  Millions$ 68.177  Millions
Roivant Sciences Ltd   0.05 $ 103.153  Millions$ 2,198.688  Millions
Quantum Cyber N v   0.05 $ 0.874  Millions$ 19.248  Millions
Syros Pharmaceuticals Inc   0.05 $ 8.795  Millions$ 194.647  Millions
Arch Therapeutics Inc   0.04 $ 0.076  Millions$ 1.708  Millions
Lexaria Bioscience Corp   0.04 $ 0.226  Millions$ 5.253  Millions
Aclarion Inc   0.04 $ 0.084  Millions$ 2.081  Millions
Co diagnostics Inc   0.04 $ 4.658  Millions$ 115.392  Millions
Longeveron Inc   0.04 $ 0.767  Millions$ 19.485  Millions
Armata Pharmaceuticals Inc   0.04 $ 4.052  Millions$ 104.647  Millions
Lucid Diagnostics Inc   0.04 $ 1.500  Millions$ 39.341  Millions
Ambrx Biopharma Inc   0.04 $ 8.602  Millions$ 227.259  Millions
Intellia Therapeutics Inc   0.04 $ 51.765  Millions$ 1,376.148  Millions
Bolt Biotherapeutics Inc   0.04 $ 7.198  Millions$ 200.010  Millions
Pavmed Inc   0.04 $ 1.923  Millions$ 53.742  Millions
Stoke Therapeutics Inc   0.04 $ 9.248  Millions$ 258.668  Millions
Mirati Therapeutics Inc   0.04 $ 38.191  Millions$ 1,070.290  Millions
Viskase Holdings inc   0.04 $ 1.648  Millions$ 46.938  Millions
Inovio Pharmaceuticals Inc   0.03 $ 9.057  Millions$ 260.313  Millions
Foxo Technologies Inc   0.03 $ 0.453  Millions$ 13.115  Millions
Seer Inc   0.03 $ 16.095  Millions$ 466.691  Millions
Cardiff Oncology Inc   0.03 $ 3.521  Millions$ 102.162  Millions
Bluebird Bio Inc   0.03 $ 21.725  Millions$ 631.160  Millions
Xoma Royalty Corporation  0.03 $ 4.411  Millions$ 130.950  Millions
Abcellera Biologics Inc   0.03 $ 50.390  Millions$ 1,522.046  Millions
Vaxart Inc   0.03 $ 4.156  Millions$ 127.998  Millions
Ainos Inc   0.03 $ 1.140  Millions$ 35.431  Millions
Volitionrx Limited  0.03 $ 0.651  Millions$ 20.485  Millions
Miromatrix Medical inc   0.03 $ 0.958  Millions$ 30.219  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.